Thomas Garrity

Track

Insider profile

Currently holds a position at Antares Pharma Inc

Positions

Position Company Period
Independent Director Antares Pharma Inc Oct. 31, 2003 -
Thomas Garrity's trades of Antares Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
119.19
Quantity 38,039 +24.9%
Value US$1,521,505
Transaction date
Planned sale
Price
53.37
Quantity 76,151 -17.5%
Value US$2,954,945
Transaction date
Planned sale
Price
385.21
Quantity 58,415 +24.8%
Value US$4,004,081
Transaction date
Planned sale
Price
4.07
Quantity 20,000 -8.2%
Value US$81,400
Transaction date
Planned sale
Price
2.67
Quantity 30,000 -15.8%
Value US$79,968
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-12 2021-03-11
PlS Planned sale
38,039 +24.9%
119.19
US$1,521,505 		38,039 +24.9% 119.19 US$1,521,505
2021-02-12 2021-02-11
PlS Planned sale
76,151 -17.5%
53.37
US$2,954,945 		76,151 -17.5% 53.37 US$2,954,945
2021-01-13 2021-01-11
PlS Planned sale
58,415 +24.8%
385.21
US$4,004,081 		58,415 +24.8% 385.21 US$4,004,081
2021-01-13 2021-01-11
PlS Planned sale
20,000 -8.2%
4.07
US$81,400 		20,000 -8.2% 4.07 US$81,400
2019-05-03 2019-05-01
PlS Planned sale
30,000 -15.8%
2.67
US$79,968 		30,000 -15.8% 2.67 US$79,968